Wnt4/β-catenin signaling pathway modulates balloon-injured carotid artery restenosis via disheveled-

来源 :浙江省中西医结合心血管病专业委员会第十六次学术年会 | 被引量 : 0次 | 上传用户:liyunlong1015
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background: Restenosis is a common adverse event of endovascular procedures and troubles cardiologists.However, the mechanism underlying restenosis is still not fully understood.To evaluate whether disheveled-1 (Dvl-1) is involved in the Wnt4/β-catenin signaling pathway to participate in the mechanisms of vascular restenosis.Methodology: Rat model of balloon-injured carotid artery was established and atorvastatin was used to treat artery injury.Vascular smooth muscle cells (VSMC) were isolated from rats and cultured in DMEM exposed to Angll.Downregulation and overexpression of Dvl-1 were conducted in cells to explore the role underlying its effects on VSMC proliferation and collagen expression.Adenovirus with overexpressing Dvl-1 was injected into rats to evaluate the role of Dvl-1 in artery injury rats.Results: The results in vivo found that Wnt4, Dvl-1 and β-catenin expression as well as collagen volume fraction (CVF) in injured artery were significantly increased.The results in vitro showed that Dvl1 overexpression reversed the treatment effects of atorvastatin on VSMCs proliferation and collagen expression.It was also canceled by overexpressing Dvl-1 that the decrease of β-catenin protein treated with atorvastatin in cells exposed to Angll.In addition, treated artery injury rats with atorvastatin, the group with injection of Ad-Dvl-1 had higher levels of intima thickness, intimal/medial area ratio and CVF.Conclusion: Dvl-1 was probably a key regulator in the pathway of wnt4/β-catenin to take part in the vascular restenosis partly, and Dvl-1 is a potential gene to anti-restenosis.
其他文献
慢性心功能不全是各种心脏疾患病情逐渐由轻到重的漫长过程,包括了无心衰症状的心功能不全代偿阶段以及晚期心力衰竭阶段.很多患者对于疾病的初期表现容易忽视,往往病重才前往就诊,从而延误病情.近年来对于心功能不全相关指标检测的研究中发现,血浆BNP水平与心功能呈正相关性,能敏感地反映心脏功能指标.近三年来,笔者采用李飞泽主任中医师的益气振心汤治疗老年性慢性心功能不全患者,并进行治疗前后血浆BNP及彩超心功
目的:观察自拟益肾复脉汤对冠心病心律失常的治疗效果.方法:将120病例随机分成治疗组68例和对照组52例,治疗组予以自拟益肾复脉汤口服,对照组予以美托洛尔片和心可舒胶囊口服.结果:治疗组显效24例,有效38例,无效6例,总有效率91.2%;对照组显效12例,有效28例,无效12例,总有效率76.9%.观察组有效率明显优于对照组(P<0.05),差异有显著性.结论:益肾复脉汤治疗冠心病心律失常具有较
右心室肥厚型心肌病少见,而右心室肥厚型心肌病合并冠脉栓塞未见文献报告,现将宁波市第一医院心脏中心收治1例介绍如下.病例摘要患者,女,65岁,以突发胸痛7小时之主诉于2015年11月13日急诊收入院.既往有"反复双下肢浮肿"病史4年余,有"阵发性房颤"病史1年,否认"高血压病、糖尿病"病史.查体:Bp128/82mmHg,无颜面部浮肿、口唇发绀、颈静脉怒张,两下肺可闻及湿性啰音,心界向左轻度扩大,H
目的:探讨原发性高血压(EH)患者颈动脉内膜中层厚度(caIMT)与血清C型钠尿肽(CNP)的关系及临床意义.方法:对156例EH患者,采用多普勒超声测定caIMT,放射免疫法测定血清CNP水平,并与60例健康对照组进行对照统计分析.结果:EH组caIMT显著高于对照组(0.82±0.16mmvs0.63±0.13mm;t=8.211,P<0.01),血清CNP(23.6±7.5ng/L VS17
目的:探讨中药汤剂对改善心肌桥患者临床症状及心电图表现的价值.方法:按照随机对照的原则对2011年3月至2014年3月浙江省中医院心内科收治的45例第一诊断为心肌桥患者进行回顾性研究分析.对照组予常规治疗(阿司匹林加康忻),治疗组常规治疗基础上加用补气活血中药汤剂口服;对比两组临床症状(包括心悸、胸闷、胸痛、气短或乏力等情况)及心电图等相关指标.结果对照组共8例患者临床症状好转或消失,治疗起效率(
目的:观察自拟中药滋肾化浊汤对老年高血压患者早期肾损害的保护效应.方法:将106例老年高血压患者早期肾损害患者随机分为观察组(n=53例)及对照组(n=53例),对照组给予常规西医治疗,观察组在常规西医治疗基础上给予自拟中药滋肾化浊汤治疗,两组均治疗12周.记录治疗前后的收缩压(SBP)、舒张压(DBP)及平均动脉压(MAP)变化情况,检测两组患者治疗前后的尿微量清蛋白(MA)及尿β2-微球蛋白(
近年来,冠心病等心血管疾病成为中国的首位死因,严重威胁人民的健康.《中国心血管病报告2013》显示,中国心脑血管疾病现患人数为2.9亿,其中心肌梗死(MI)患者250万,心血管患病率处于持续上升阶段,2008年中国卫生服务调查研究结果显示,城市地区缺血性心脏病的患病率为15.9‰,农村地区为4.8‰,城乡合计为7.7‰,较2003年第三次调查结果大幅度升高.分析了冠心病流行病学以及ACEI应用现状
本文阐述了PCI导丝的选择及操作。具体介绍常规软性缠绕型导引钢丝、CTO导丝以及强支撑导丝的性能指标。分析了导丝的选择,给出了次冠状动脉次全闭病变、全闭病变病例分享。
本文具体阐述了急性心肌梗死疾病分型、诊断标准、心电图特征、急诊流程以及溶栓治疗、抗血小板治疗、抗凝治疗、抗心肌治疗等疗法适应症、禁忌症、质量控制标准。
Upon lipopolysaccharide (LPS) stimulation, phosphoinositide 3-kinase (PI3K)/Akt pathways serves to banlance proinflammatory and anti-inflammatory responses.However, the mechanism underlying Akt signal